The future of mifepristone, a crucial abortion drug, is currently under question as US courts consider a challenge brought by anti-abortion groups. Considering medication is the most common US abortion method, it is the most significant reproductive rights case to make its way through the courts since Roe v Wade was overturned in 2022. The groups suing the Food and Drug Administration over its approval of the drug claim that the drug poses a threat to women and girls – contrary to scientific consensus – and should never have been approved by the FDA more than two decades ago. The...